{
    "organizations": [],
    "uuid": "116b86cb6acfd612528665ce4972dfa2a8b40629",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-basilea-announces-completion-of-li/brief-basilea-announces-completion-of-license-agreement-extension-with-pfizer-idUSFWN1P412J",
    "ord_in_thread": 0,
    "title": "BRIEF-Basilea Announces Completion Of License Agreement Extension With Pfizer",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 10 (Reuters) - Basilea Pharmaceutica AG:\n* BASILEA ANNOUNCES COMPLETION OF THE LICENSE AGREEMENT EXTENSION WITH PFIZER FOR ANTIFUNGAL CRESEMBA FOR CHINA AND ASIA PACIFIC Source text for Eikon: Further company coverage: (Gdynia Newsroom)\nOur Standards: The Thomson Reuters Trust Principles.",
    "published": "2018-01-10T14:21:00.000+02:00",
    "crawled": "2018-01-11T12:45:07.001+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "basilea",
        "pharmaceutica",
        "ag",
        "basilea",
        "announces",
        "completion",
        "license",
        "agreement",
        "extension",
        "pfizer",
        "antifungal",
        "cresemba",
        "china",
        "asia",
        "pacific",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "gdynia",
        "newsroom",
        "standard",
        "thomson",
        "reuters",
        "trust",
        "principle"
    ]
}